Elekta AB (publ) (EKTA-B.ST)
SEK 61.7
(2.32%)
SEK 61.7
(2.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.29 Billion SEK | 40.71% |
| 2022 | 2.56 Billion SEK | -7.51% |
| 2021 | 2.73 Billion SEK | -12.36% |
| 2020 | 3.13 Billion SEK | 4.21% |
| 2019 | 2.98 Billion SEK | 9.65% |
| 2018 | 2.7 Billion SEK | 20.58% |
| 2017 | 2.57 Billion SEK | 29.27% |
| 2016 | 1.28 Billion SEK | 3.67% |
| 2015 | 1.09 Billion SEK | 14.71% |
| 2014 | 1.44 Billion SEK | -36.46% |
| 2013 | 2.16 Billion SEK | -5.75% |
| 2012 | 2.4 Billion SEK | 10.36% |
| 2011 | 2.2 Billion SEK | 24.28% |
| 2010 | 1.76 Billion SEK | 19.85% |
| 2009 | 1.46 Billion SEK | 35.08% |
| 2008 | 1.08 Billion SEK | 37.15% |
| 2007 | 866 Million SEK | 11.2% |
| 2006 | 697 Million SEK | 5.93% |
| 2005 | 659 Million SEK | 42.19% |
| 2004 | 467 Million SEK | 29.16% |
| 2003 | 367 Million SEK | -1.61% |
| 2002 | 373 Million SEK | 47.43% |
| 2001 | 253 Million SEK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 413 Million SEK | -46.92% |
| 2023 Q1 | 723 Million SEK | 3.29% |
| 2023 Q2 | 857 Million SEK | 18.53% |
| 2023 Q3 | 794 Million SEK | -7.35% |
| 2023 Q4 | 858 Million SEK | 8.06% |
| 2023 FY | - SEK | 40.71% |
| 2022 Q2 | 608 Million SEK | 36.02% |
| 2022 Q3 | 733 Million SEK | 20.56% |
| 2022 FY | - SEK | -7.51% |
| 2022 Q4 | 700 Million SEK | -4.5% |
| 2022 Q1 | 447 Million SEK | -55.43% |
| 2021 Q3 | 547 Million SEK | -25.27% |
| 2021 Q4 | 1 Billion SEK | 83.36% |
| 2021 Q2 | 732 Million SEK | 80.74% |
| 2021 Q1 | 405 Million SEK | -50.06% |
| 2021 FY | - SEK | -12.36% |
| 2020 Q3 | 748 Million SEK | -6.85% |
| 2020 FY | - SEK | 4.21% |
| 2020 Q1 | 706 Million SEK | -26.38% |
| 2020 Q2 | 803 Million SEK | 13.74% |
| 2020 Q4 | 811 Million SEK | 8.42% |
| 2019 FY | - SEK | 9.65% |
| 2019 Q1 | 567 Million SEK | -44.3% |
| 2019 Q2 | 662 Million SEK | 16.75% |
| 2019 Q3 | 755 Million SEK | 14.05% |
| 2019 Q4 | 959 Million SEK | 27.02% |
| 2018 FY | - SEK | 20.58% |
| 2018 Q4 | 1.01 Billion SEK | 82.76% |
| 2018 Q3 | 557 Million SEK | -15.35% |
| 2018 Q2 | 658 Million SEK | 47.2% |
| 2018 Q1 | 447 Million SEK | -52.29% |
| 2017 Q4 | 937 Million SEK | 77.13% |
| 2017 Q3 | 529 Million SEK | -3.29% |
| 2017 Q2 | 547 Million SEK | 148.64% |
| 2017 Q1 | 220 Million SEK | -71.17% |
| 2017 FY | - SEK | 29.27% |
| 2016 Q1 | 210 Million SEK | -72.22% |
| 2016 Q2 | 414 Million SEK | 97.14% |
| 2016 Q3 | 339 Million SEK | -18.12% |
| 2016 Q4 | 763 Million SEK | 125.07% |
| 2016 FY | - SEK | 3.67% |
| 2015 Q1 | 90 Million SEK | -85.32% |
| 2015 Q4 | 756 Million SEK | 136.99% |
| 2015 Q3 | 319 Million SEK | -35.69% |
| 2015 Q2 | 496 Million SEK | 451.11% |
| 2015 FY | - SEK | 14.71% |
| 2014 Q4 | 613 Million SEK | 57.99% |
| 2014 FY | - SEK | -36.46% |
| 2014 Q3 | 388 Million SEK | -12.42% |
| 2014 Q2 | 443 Million SEK | 10975.0% |
| 2014 Q1 | 4 Million SEK | -99.69% |
| 2013 Q4 | 1.29 Billion SEK | 253.68% |
| 2013 FY | - SEK | -5.75% |
| 2013 Q1 | 175 Million SEK | -85.37% |
| 2013 Q2 | 439 Million SEK | 150.86% |
| 2013 Q3 | 367 Million SEK | -16.4% |
| 2012 Q2 | 502 Million SEK | 709.68% |
| 2012 Q3 | 386 Million SEK | -23.11% |
| 2012 Q4 | 1.19 Billion SEK | 209.84% |
| 2012 FY | - SEK | 10.36% |
| 2012 Q1 | 62 Million SEK | -91.18% |
| 2011 Q3 | 639 Million SEK | 58.17% |
| 2011 Q4 | 703 Million SEK | 10.02% |
| 2011 FY | - SEK | 24.28% |
| 2011 Q1 | 103 Million SEK | -86.57% |
| 2011 Q2 | 404 Million SEK | 292.23% |
| 2010 Q1 | 160 Million SEK | -76.4% |
| 2010 Q4 | 767 Million SEK | 162.67% |
| 2010 FY | - SEK | 19.85% |
| 2010 Q3 | 292 Million SEK | -3.63% |
| 2010 Q2 | 303 Million SEK | 89.38% |
| 2009 Q1 | 97 Million SEK | 0.0% |
| 2009 Q3 | 227 Million SEK | -5.42% |
| 2009 Q2 | 240 Million SEK | 147.42% |
| 2009 Q4 | 678 Million SEK | 198.68% |
| 2009 FY | - SEK | 35.08% |
| 2008 FY | - SEK | 37.15% |
| 2007 FY | - SEK | 11.2% |
| 2006 FY | - SEK | 5.93% |
| 2005 FY | - SEK | 42.19% |
| 2004 FY | - SEK | 29.16% |
| 2003 FY | - SEK | -1.61% |
| 2002 FY | - SEK | 47.43% |
| 2001 FY | - SEK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AddLife AB (publ) | 1.54 Billion SEK | -112.872% |
| Biotage AB (publ) | 432 Million SEK | -661.806% |
| Bonesupport Holding AB (publ) | 28.93 Million SEK | -11272.983% |
| Doxa AB (publ) | 296 Million SEK | -1011.824% |
| iZafe Group AB (publ) | -15.61 Million SEK | 21173.189% |
| Ortivus AB (publ) | -14.92 Million SEK | 22148.774% |
| Ortivus AB (publ) | -14.92 Million SEK | 22148.774% |
| Q-linea AB (publ) | -210.98 Million SEK | 1659.819% |
| S2Medical AB (publ) | -13.52 Million SEK | 24425.296% |
| Synsam AB (publ) | 1.71 Billion SEK | -92.344% |